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Purpose: The aim of this study was to determine the causes of hemoptysis in a pediatric age group. Methods: We conducted a retrospective 
chart review of all patients who were admitted to Samsung Medical Center between 1996 and 2008 with a chief complaint of hemoptysis. 
Patients with trauma or underlying bleeding tendency such as leukemia were excluded. Patients were divided into three groups according to age 
(0 to 5 yr, 6 to 10 yr, and 11 to 18 yr). The amount of hemoptysis was classified as mild (≤20 mL/day), moderate (20-100 mL/day), or massive (>100 
mL/day). Causes and duration of hemoptysis, disease course, and mortality were also investigated. Results: A total of 40 patients (18 males and 
22 females) were identified. Their median age was 6.3 yr (range, 10 months to 18 yr). Twenty-five patients manifested mild hemoptysis; moderate 
and massive hemoptysis were found in nine and six patients, respectively. Respiratory tract infection was the most common cause of hemoptysis. 
Other causes included congenital heart disease, Heiner syndrome, neoplasm in the airway, vasculitis syndrome, and bronchiectasis. In most 
patients (87.5%), hemoptysis disappeared during medical treatment that included antibiotics or transfusion. Hemoptysis recurred in 12 patients, 
and the overall mortality rate was 5%. Conclusions: The most common cause of hemoptysis in children was respiratory tract infection. Most 
cases had a benign course, but recurrence and mortality occurred in a minority of patients. An accurate diagnosis of the underlying etiology is 
essential for treatment.
Key Words: hemoptysis; children; etiology
INTRODUCTION
Hemoptysis is the extra-oral release of blood emitted from the 
nose or mouth to the respiratory system, including the lungs. 
Pediatric cases of hemoptysis are uncommon, but some chil-
dren experience life-threatening events.
1 The common diag-
nostic evaluation usually consist s of a simple roentgenogram, 
computed tomography, bronchoscopy, and culture studies, al-
though some of these are not easily available in clinical practice 
for children. A guideline or diagnostic algorithm based on com-
mon etiologies for pediatric hemoptysis in each community 
would be helpful.
Various etiologies of hemoptysis have been reported, depend-
ing on age and location. Adult cases of hemoptysis mainly oc-
cur as a result of infection, bronchial adenoma, or telangiecta-
sia.
2,3 However, in pediatric cases, major causative factors 
include infection, foreign body aspiration, and congenital heart 
diseases.
4 In contrast, in Korea, pulmonary tuberculosis, lung 
cancer, and telangiectasia are causative factors for hemoptysis 
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in adults.
5 In Korean pediatric patients, despite the publication 
of some cases,
6-8 major causative diseases for hemoptysis have 
not yet been reported. In this study, we analyzed the etiologies 
and clinical characteristics of hemoptysis in Korean children.
MATERIALS AND METHODS
The medical records of 40 patients aged 18 yr or younger who 
were admitted to the Department of Pediatrics, Samsung Seoul 
Hospital, Seoul, Korea between January 1996 and June 2008 
with a chief complaint of hemoptysis were reviewed retrospec-
tively, to assess gender, age distribution, amount of hemoptysis, 
causative diseases, treatment modalities, and prognosis. Pa-
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tients with trauma, bleeding tendency, cancer, or hematologic 
disorders were excluded. According to the age distributions, 
patients were classified into an early childhood group (0–5 yr), 
late childhood group (6–10 yr), and adolescent group (≥11 yr). 
The amount of hemoptysis in 24 hr was estimated to be minimal 
(≤20 mL), moderate (21–100 mL) or massive (>100 mL), based 
on the approximate amount of hemoptysis in one episode (<5, 
50, or 100 mL) and the frequency of hemoptysis in 1 day.
9
Treatment modalities were divided into medical treatments, 
including antibiotic administration, blood transfusion, and 
other conservative treatment, and surgical treatments, includ-
ing bronchial artery embolization and surgery. Recurrence and 
prognosis were assessed based on a retrospective analysis of 
the medical records during the mean follow-up period, which 
was 27 months (range, 1–204 months).
RESULTS
Patient age and gender distribution 
The 40 patients consisted of 18 boys and 22 girls, and the male-
to-female ratio was 1:1.2. Patient age ranged from 10 months to 
18 yr, with a median age of 6 yr and 3 months. Seventeen pa-
tients were included in the early childhood group; 8 in the late 
childhood; and 15 in the adolescent group.
Clinical characteristics
The median length of hospital stay was 6 days (range, 3–38 
days). The diagnosis of the patient who was hospitalized for the 
longest period (38 days) was Heiner syndrome. The duration of 
hemoptysis ranged from 1 to 19 days, with a median period of 5 
days. The longest duration (19 days) was in a patient with idio-
pathic pulmonary hemosiderosis. Of the 40 patients, there were 
25 (62.5%) patients with a minimal amount of hemoptysis, 
whereas six children showed a massive amount of hemoptysis.
Causative diseases
The main causative disease was respiratory tract infection 
(25%), followed by congenital heart diseases (17.5%). Addition-
ally, there were four cases of Heiner syndrome (10%), three of 
respiratory neoplasm (7.5%), three of vasculitis syndrome 
(7.5%), three of bronchiectasis (7.5%), two of upper airway 
bleeding (5%), and four idiopathic cases (10%) (Table 1).
The etiology of hemoptysis was also assessed according to the 
age distribution. Infection, Heiner syndrome, and congenital 
heart disease were the major causative diseases in early child-
hood. During late childhood, various causative diseases such 
as vasculitis syndrome, bronchial tumor, and bronchiectasis 
were present. In the adolescent group, hemoptysis was mainly 
caused by infection and congenital heart disease, and bronchi-
ectasis and bronchial neoplasms were causative diseases in this 
age group (Table 2).
The patients with bronchiectasis, infection, congenital heart 
disease, or bronchial neoplasms showed a moderate or mas-
sive amount of bleeding, although no difference in the amount 
of hemoptysis was observed based on etiology (Table 3).
Treatment modalities
Hemoptysis disappeared in 35 patients (87.5%) with medical 
management alone, and surgical treatment was required in the 
remaining five patients. Three children with bronchial tumors 
received a lobectomy with tumor removal. A bronchial artery 
embolization was performed in one patient with a pulmonary 
arteriovenous fistula. A patient with a vascular malformation 
on the larynx was treated under general anesthesia with elec-
trocauterization using rigid bronchoscopy.
Prognosis
Of the 40 patients, hemoptysis recurred in 12 (30%), whose 
causative diseases included Heiner syndrome and vasculitis 
syndrome. There were two cases of mortality (5%), one due to 
systemic lupus erythematosus and one due to lymphangioma-
tosis. The cause of death was persistent hemoptysis and subse-
quent respiratory failure.
Table 1. Etiology of hemoptysis in children
Etiology Number of patients
Infection 10 
        Pharyngitis
        Bronchitis 
        Pneumonia
        Tuberculosis
3
3
2
2
Congenital heart disease 7
        Eisenmenger syndrome
        Pulmonary vein stenosis
        Pulmonary atresia with VSD
        Primary pulmonary hypertension
        Pulmonary artery agenesis
2
2
1
1
1 
Heiner syndrome 4
Neoplasm (mucoepidermoid carcinoma) 3
Vasculitis syndrome 3
        Henoch-Scho_nlein purpura
        Systemic lupus erythematosus
2
1
Bronchiectasis 3
Upper airway bleeding 2
        Epistaxis
        Vascular malformation on larynx
1
1
Other 4
        Pulmonary arteriovenous fistula
        Bronchogenic cyst
        Idiopathic pulmonary hemosiderosis
        Lymphangiomatosis
1
1
1
1
Unknown 4
Total 40 
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DISCUSSION
Hemoptysis is not a common chief complaint in pediatric pa-
tients and is rarely life-threatening; therefore, a thorough inves-
tigation is necessary to identify the disease causing the hemop-
tysis. Infection is one of the most common etiologies for 
hemoptysis in children,
4,10-12 however, a 10-yr retrospective 
study of pediatric hemoptysis in the US showed that cystic fi-
brosis was the most common cause, followed by congenital 
heart disease and infection.
13 The etiology of hemoptysis in 
children may depend on race, region, and research methodol-
ogy. In this study, infection and congenital heart disease were 
the common causes for pediatric hemoptysis in Korea. Al-
though this is the first report on the etiology of hemoptysis in 
Korean children, selection bias should be considered, because 
the results were obtained from a single, tertiary medical institu-
tion. Therefore, multi-center studies are warranted to obtain 
more accurate information regarding the common etiology of 
hemoptysis in Korean children. 
The hemoptysis pattern based on age distribution was exam-
ined. Coss-Bu et al.
13 reported in a US study that pediatric he-
moptysis was most commonly noted in an adolescent group, 
11 yr or older. However, we found it to be common in pediatric 
patients aged 5 yr or younger as well as those aged 11 yr or old-
er. Our study showed that Heiner syndrome and congenital 
heart disease were the second most common causes for he-
moptysis in the early childhood group. This is conceivable be-
cause food allergy and congenital diseases begin to manifest 
clinical symptoms during this period. Congenital heart disease 
was also a common cause of hemoptysis in the adolescent 
group of our study, which is consistent with a previous study in 
which hemoptysis was related to congenital heart disease and 
had a bimodal age distribution.
13 Massive bleeding occurred in 
15% of patients in our study, whereas in previous studies, ap-
proximately 5% had daily massive bleeding of >200 mL.
9,10 
These discrepancies may be attributable to differences in un-
derlying diseases, the method used to estimate the amount of 
bleeding, or criteria for determining massive bleeding. For ex-
ample, cystic fibrosis leads to a massive amount of hemoptysis 
in children,
14,15 but it is a rare disease in the Korean popula-
tion.
16 In our series, bronchiectasis was the most common etiol-
ogy in children with massive hemoptysis. None of the three pa-
tients with bronchiectasis had underlying causes such as cystic 
fibrosis or primary ciliary dyskinesia.
The amount of bleeding is minimal in most pediatric hemop-
tysis cases, and symptoms improve with conservative treat-
ment.
9,11 In the current study, 62.5% of cases had a minimal 
amount of hemoptysis, and in most cases (87.5%), hemoptysis 
improved with medical management alone. However, during 
the mean follow-up period of 27 months, hemoptysis recurred 
in 30% of patients. Mortality from hemoptysis is reported as 
0–32% in children.
11,14,15  It was 5% in the current study, and the 
cause of death was progression of respiratory failure due to pul-
monary hemorrhage, rather than asphyxiation or shock by ex-
Table 3. Etiology of hemoptysis according to the amount of hemoptysis
Etiology Number of patients
Mild amount  25 
        Infection
        Congenital heart diasese 
        Heiner syndrome
        Vasculitis syndrome
        Neoplasm 
        Upper airway bleeding
        Others
        Unknown
8
5
2
2
1
1
2
4
Moderate amount 9
        Congenital heart disease 
        Infection 
        Neoplasm
        Heiner syndrome
        Upper airway bleeding
        Others 
2
2
2
1
1
1 
Massive amount 6
        Bronchiectasis 
        Heiner syndrome 
        Vasculitis syndrome
        Others 
3
1
1
1
Table 2. Etiology of hemoptysis according to the age
Etiology Number of patients
Early childhood (0-5 yr)  17 
       Infection
       Heiner syndrome 
       Congenital heart diasese
       Upper airway bleeding
       Others
       Unknown
6
4
3
1
2
1  
Late childhood (6-10 yr) 8
       Vasculitis syndrome
       Neoplasm
       Infection
       Congenital heart disease
       Bronchiectasis
       Unknown
2
1
1
1
1
2 
Adolescence (11-18 yr) 15
       Congenital heart disease
       Infection 
       Bronchiectasis 
       Neoplasm 
       Vasculitis syndrome
       Upper airway bleeding
       Others 
       Unknown 
3
3
2
2
1
1
2
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cessive bleeding. Considering that the common causes of he-
moptysis in our study included chronic diseases such as Heiner 
syndrome and vasculitis syndrome, a long-term follow-up 
study is mandatory to determine the clinical course and recur-
rence of hemoptysis based on underlying diseases in pediatric 
patients.
In conclusion, the most common etiology in pediatric pa-
tients with hemoptysis was respiratory infection. In most cases, 
the amount of hemoptysis was minimal. These cases showed a 
good clinical course in which the symptoms were improved by 
conservative treatment alone; however, in some cases, a recur-
rence of hemoptysis was observed or surgical management was 
necessary. An accurate diagnosis of underlying diseases is es-
sential for the treatment of hemoptysis.
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